Course Directors

Alfonso Fasano, MD, PhD, FAAN - University of Toronto; Toronto, Canada

Connie Marras, MD, PhD - University of Toronto; Toronto, Canada

Course Faculty

Jeanne Feuerstein, MD - University of Colorado; Aurora, Colorado, USA.

Thomas Foltynie, PhD, MRCP - National Hospital for Neurology; London, United Kingdom

Leonidas Stefanis,MD, PhD - National and Kapodistrian University of Athens Medical School; Athens, Greece

As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner. 

There will be a patient/caregiver roundtable session in the program to enrich the participant’s knowledge on how PD impacts patients and their caregivers. 

The primary purpose of this program is to provide industry professionals with a basic knowledge of Parkinson's disease from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.

Registration Fees

Members: $800 USD

Non-Members: $800 USD

Upon completion of this activity, learners will be able to:

1. Recognize the differential diagnosis of Parkinson’s disease

2. Discuss the clinical features of Parkinson’s disease from early to advanced stages

3. Identify the benefits, limitations and complications of currently available treatments for PD including pharmacotherapy and surgery

4. Discuss non-motor features of Parkinson’s disease

5. Identify outcome measures, unmet needs, emerging therapies, and biomarkers for Parkinson’s disease

This activity is intended for industry professionals who work for pharmaceutical and medical device companies.

Industry Course Seoul Agenda - Final.pdf

COEX Convention and Exhibition Center, Seoul South Korea
Click here to view location map